<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39381033</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2673-8880</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in nuclear medicine (Lausanne, Switzerland)</Title><ISOAbbreviation>Front Nucl Med</ISOAbbreviation></Journal><ArticleTitle>An assessment of PET and CMR radiomic features for the detection of cardiac sarcoidosis.</ArticleTitle><Pagination><StartPage>1324698</StartPage><MedlinePgn>1324698</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1324698</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnume.2024.1324698</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Visual interpretation of PET and CMR may fail to identify cardiac sarcoidosis (CS) with high specificity. This study aimed to evaluate the role of [<sup>18</sup>F]FDG PET and late gadolinium enhancement (LGE)-CMR radiomic features in differentiating CS from another cause of myocardial inflammation, in this case patients with cardiac-related clinical symptoms following COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">[<sup>18</sup>F]FDG PET and LGE-CMR were treated separately in this work. There were 35 post-COVID-19 (PC) and 40 CS datasets. Regions of interest were delineated manually around the entire left ventricle for the PET and LGE-CMR datasets. Radiomic features were then extracted. The ability of individual features to correctly identify image data as CS or PC was tested to predict the clinical classification of CS vs. PC using Mann-Whitney <i>U</i>-tests and logistic regression. Features were retained if the <i>P</i>-value was &lt;0.00053, the AUC was &gt;0.5, and the accuracy was &gt;0.7. After applying the correlation test, uncorrelated features were used as a signature (joint features) to train machine learning classifiers. For LGE-CMR analysis, to further improve the results, different classifiers were used for individual features besides logistic regression, and the results of individual features of each classifier were screened to create a signature that included all features that followed the previously mentioned criteria and used it them as input for machine learning classifiers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The Mann-Whitney <i>U</i>-tests and logistic regression were trained on individual features to build a collection of features. For [<sup>18</sup>F]FDG PET analysis, the maximum target-to-background ratio (<i>TBR<sub>max</sub></i> ) showed a high area under the curve (AUC) and accuracy with small <i>P</i>-values (&lt;0.00053), but the signature performed better (AUC 0.98 and accuracy 0.91). For LGE-CMR analysis, the <i>Gray Level Dependence Matrix (gldm)-Dependence Non-Uniformity</i> showed good results with small error bars (accuracy 0.75 and AUC 0.87). However, by applying a Support Vector Machine classifier to individual LGE-CMR features and creating a signature, a Random Forest classifier displayed better AUC and accuracy (0.91 and 0.84, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Using radiomic features may prove useful in identifying individuals with CS. Some features showed promising results in differentiating between PC and CS. By automating the analysis, the patient management process can be accelerated and improved.</AbstractText><CopyrightInformation>© 2024 Mushari, Soultanidis, Duff, Trivieri, Fayad, Robson and Tsoumpas.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mushari</LastName><ForeName>Nouf A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soultanidis</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duff</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beatson Institute for Cancer Research, University of Glasgow, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trivieri</LastName><ForeName>Maria G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fayad</LastName><ForeName>Zahi A</ForeName><Initials>ZA</Initials><AffiliationInfo><Affiliation>BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robson</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsoumpas</LastName><ForeName>Charalampos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL071021</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Nucl Med</MedlineTA><NlmUniqueID>9918470388806676</NlmUniqueID><ISSNLinking>2673-8880</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PET-MRI</Keyword><Keyword MajorTopicYN="N">cardiac sarcoidosis</Keyword><Keyword MajorTopicYN="N">imaging</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were editorial board members of Frontiers at the time of submission. This had no impact on the peer review process or the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>4</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39381033</ArticleId><ArticleId IdType="pmc">PMC11460291</ArticleId><ArticleId IdType="doi">10.3389/fnume.2024.1324698</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lehtonen J, Uusitalo V, Pöyhönen P, Mäyränpää MI, Kupari M. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J. (2023) 44(17):1495–510. 10.1093/eurheartj/ehad067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad067</ArticleId><ArticleId IdType="pmc">PMC10149532</ArticleId><ArticleId IdType="pubmed">36924191</ArticleId></ArticleIdList></Reference><Reference><Citation>Divakaran S, Stewart GC, Lakdawala NK, Padera RF, Zhou W, Desai AS, et al. Diagnostic accuracy of advanced imaging in cardiac sarcoidosis: an imaging-histologic correlation study in patients undergoing cardiac transplantation. Circ Cardiovasc Imaging. (2019) 12(6):e008975. 10.1161/CIRCIMAGING.118.008975</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.118.008975</ArticleId><ArticleId IdType="pmc">PMC6653689</ArticleId><ArticleId IdType="pubmed">31177817</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne MT, Hulten EA, Murthy VL, Skali H, Taqueti VR, Dorbala S, et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol. (2017) 24(1):86–99. 10.1007/s12350-016-0502-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12350-016-0502-7</ArticleId><ArticleId IdType="pmc">PMC5841447</ArticleId><ArticleId IdType="pubmed">27277502</ArticleId></ArticleIdList></Reference><Reference><Citation>Mushari NA, Soultanidis G, Duff L, Trivieri MG, Fayad ZA, Robson PM, et al. Exploring the utility of cardiovascular magnetic resonance radiomic feature extraction for evaluation of cardiac sarcoidosis. Diagnostics. (2023) 13(11):1865. 10.3390/diagnostics13111865</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13111865</ArticleId><ArticleId IdType="pmc">PMC10252949</ArticleId><ArticleId IdType="pubmed">37296722</ArticleId></ArticleIdList></Reference><Reference><Citation>Smedema J-P, Snoep G, van Kroonenburgh MP, van Geuns R-J, Dassen WR, Gorgels AP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. (2005) 45(10):1683–90. 10.1016/j.jacc.2005.01.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2005.01.047</ArticleId><ArticleId IdType="pubmed">15893188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinose A, Otani H, Oikawa M, Takase K, Saito H, Shimokawa H, et al. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. Am J Roentgenol. (2008) 191(3):862–9. 10.2214/AJR.07.3089</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.07.3089</ArticleId><ArticleId IdType="pubmed">18716120</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamori S, Neisius U, Nezafat M, Jang J, Ngo LH, Rodriguez J, et al. Multiparametric mapping approach for detection of cardiac involvement in systemic sarcoidosis. Cardiovasc Imaging. (2020) 13(9):2058–60.</Citation><ArticleIdList><ArticleId IdType="pubmed">32563633</ArticleId></ArticleIdList></Reference><Reference><Citation>Skali H, Schulman AR, Dorbala S. 18 F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep. (2013) 15(4):370. 10.1007/s11886-013-0370-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-013-0370-6</ArticleId><ArticleId IdType="pmc">PMC4009625</ArticleId><ArticleId IdType="pubmed">23544184</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal NR, Snipelisky D, Young PM, Gersh BJ, Cooper LT, Chareonthaitawee P. Advances in imaging for diagnosis and management of cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging. (2015) 16(9):949–58. 10.1093/ehjci/jev142</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jev142</ArticleId><ArticleId IdType="pubmed">26104960</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. (2014) 11(7):1304–23. 10.1016/j.hrthm.2014.03.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2014.03.043</ArticleId><ArticleId IdType="pubmed">24819193</ArticleId></ArticleIdList></Reference><Reference><Citation>Terasaki F, Yoshinaga K. New guidelines for diagnosis of cardiac sarcoidosis in Japan. Ann Nucl Cardiol. (2017) 3(1):42–5. 10.17996/anc.17-00042</Citation><ArticleIdList><ArticleId IdType="doi">10.17996/anc.17-00042</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, et al. Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis. JACC Cardiovasc Imaging. (2018) 11(1):94–107. 10.1016/j.jcmg.2017.02.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2017.02.021</ArticleId><ArticleId IdType="pmc">PMC5995315</ArticleId><ArticleId IdType="pubmed">28624396</ArticleId></ArticleIdList></Reference><Reference><Citation>Vita T, Okada DR, Veillet-Chowdhury M, Bravo PE, Mullins E, Hulten E, et al. Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. (2018) 11(1):e007030. 10.1161/CIRCIMAGING.117.007030</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.117.007030</ArticleId><ArticleId IdType="pmc">PMC6381829</ArticleId><ArticleId IdType="pubmed">29335272</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainey C, O'Regan T, Matthew J, Skelton E, Woznitza N, Chu K-Y, et al. An insight into the current perceptions of UK radiographers on the future impact of AI on the profession: a cross-sectional survey. J Med Imaging Radiat Sci. (2022) 53(3):347–61. 10.1016/j.jmir.2022.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmir.2022.05.010</ArticleId><ArticleId IdType="pubmed">35715359</ArticleId></ArticleIdList></Reference><Reference><Citation>Duff L, Scarsbrook AF, Mackie SL, Frood R, Bailey M, Morgan AW, et al. A methodological framework for AI-assisted diagnosis of active aortitis using radiomic analysis of FDG PET–CT images: initial analysis. J Nucl Cardiol. (2022) 29:1–17. 10.1007/s12350-022-02927-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12350-022-02927-4</ArticleId><ArticleId IdType="pmc">PMC9834376</ArticleId><ArticleId IdType="pubmed">35322380</ArticleId></ArticleIdList></Reference><Reference><Citation>Tingen HSA, van Praagh GD, Nienhuis PH, Tubben A, van Rijsewijk ND, Ten Hove D, et al. The clinical value of quantitative cardiovascular molecular imaging: a step towards precision medicine. Br J Radiol. (2023) 96(1152):20230704. 10.1259/bjr.20230704</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/bjr.20230704</ArticleId><ArticleId IdType="pmc">PMC10646628</ArticleId><ArticleId IdType="pubmed">37786997</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzo S, Botta F, Raimondi S, Origgi D, Fanciullo C, Morganti AG, et al. Radiomics: the facts and the challenges of image analysis. Eur Radiol Exp. (2018) 2(1):1–8. 10.1186/s41747-018-0068-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41747-018-0068-z</ArticleId><ArticleId IdType="pmc">PMC6234198</ArticleId><ArticleId IdType="pubmed">30426318</ArticleId></ArticleIdList></Reference><Reference><Citation>Basran PS, Porter I. Radiomics in veterinary medicine: overview, methods, and applications. Vet Radiol Ultrasound. (2022) 63:828–39. 10.1111/vru.13156</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/vru.13156</ArticleId><ArticleId IdType="pubmed">36514226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. (2016) 278(2):563. 10.1148/radiol.2015151169</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2015151169</ArticleId><ArticleId IdType="pmc">PMC4734157</ArticleId><ArticleId IdType="pubmed">26579733</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan A, Wong F, Couch LS, Wang BX. Cardiac complications of COVID-19 in low-risk patients. Viruses. (2022) 14(6):1322. 10.3390/v14061322</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14061322</ArticleId><ArticleId IdType="pmc">PMC9228093</ArticleId><ArticleId IdType="pubmed">35746793</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging. (2012) 30(9):1323–41. 10.1016/j.mri.2012.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mri.2012.05.001</ArticleId><ArticleId IdType="pmc">PMC3466397</ArticleId><ArticleId IdType="pubmed">22770690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikinis R, Pieper SD, Vosburgh KG. 3D slicer: a platform for subject-specific image analysis, visualization, and clinical support. In: Jolesz FA, editor. Intraoperative Imaging and Image-Guided Therapy. New York, NY: Springer; (2014). p. 277–89.</Citation></Reference><Reference><Citation>Mushari NA, Soultanidis G, Duff L, Trivieri MG, Fayad ZA, Robson P, et al. Exploring the utility of radiomic feature extraction to improve the diagnostic accuracy of cardiac sarcoidosis using FDG PET. Front Med (Lausanne). (2022) 9:840261. 10.3389/fmed.2022.840261</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.840261</ArticleId><ArticleId IdType="pmc">PMC8920041</ArticleId><ArticleId IdType="pubmed">35295595</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Griethuysen JJ, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. (2017) 77(21):e104–7. 10.1158/0008-5472.CAN-17-0339</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-17-0339</ArticleId><ArticleId IdType="pmc">PMC5672828</ArticleId><ArticleId IdType="pubmed">29092951</ArticleId></ArticleIdList></Reference><Reference><Citation>Leijenaar RT, Nalbantov G, Carvalho S, Van Elmpt WJ, Troost EG, Boellaard R, et al. The effect of SUV discretization in quantitative FDG-PET radiomics: the need for standardized methodology in tumor texture analysis. Sci Rep. (2015) 5(1):11075. 10.1038/srep11075</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11075</ArticleId><ArticleId IdType="pmc">PMC4525145</ArticleId><ArticleId IdType="pubmed">26242464</ArticleId></ArticleIdList></Reference><Reference><Citation>Duron L, Balvay D, Vande Perre S, Bouchouicha A, Savatovsky J, Sadik J-C, et al. Gray-level discretization impacts reproducible MRI radiomics texture features. PLoS One. (2019) 14(3):e0213459. 10.1371/journal.pone.0213459</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0213459</ArticleId><ArticleId IdType="pmc">PMC6405136</ArticleId><ArticleId IdType="pubmed">30845221</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in python. J Mach Learn Res. (2011) 12:2825–30.</Citation></Reference><Reference><Citation>Steyerberg EW. Validation in prediction research: the waste by data splitting. J Clin Epidemiol. (2018) 103:131–3. 10.1016/j.jclinepi.2018.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2018.07.010</ArticleId><ArticleId IdType="pubmed">30063954</ArticleId></ArticleIdList></Reference><Reference><Citation>Akerele MI, Mushari NA, Forsythe RO, Syed M, Karakatsanis NA, Newby DE, et al. Assessment of different quantification metrics of [18 F]-NaF PET/CT images of patients with abdominal aortic aneurysm. J Nucl Cardiol. (2020) 29:1–11. 10.1007/s12350-020-02220-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12350-020-02220-2</ArticleId><ArticleId IdType="pmc">PMC8873073</ArticleId><ArticleId IdType="pubmed">32557152</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolova I, Ego K, Steffen IG, Buchert R, Wertzel H, Achenbach HJ, et al. The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers. Eur J Nucl Med Mol Imaging. (2016) 43:2360–73. 10.1007/s00259-016-3452-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-016-3452-z</ArticleId><ArticleId IdType="pubmed">27470327</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng N-M, Fang Y-HD, Tsan D-L, Hsu C-H, Yen T-C. Respiration-averaged CT for attenuation correction of PET images–impact on PET texture features in non-small cell lung cancer patients. PLoS One. (2016) 11(3):e0150509. 10.1371/journal.pone.0150509</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0150509</ArticleId><ArticleId IdType="pmc">PMC4773107</ArticleId><ArticleId IdType="pubmed">26930211</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwanenburg A. Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis. Eur J Nucl Med Mol Imaging. (2019) 46(13):2638–55. 10.1007/s00259-019-04391-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-019-04391-8</ArticleId><ArticleId IdType="pubmed">31240330</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S, Woo S, Suh CH, Kim YJ, Oh JS, Lee JJ. A systematic review of the prognostic value of texture analysis in 18 F-FDG PET in lung cancer. Ann Nucl Med. (2018) 32:602–10. 10.1007/s12149-018-1281-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12149-018-1281-9</ArticleId><ArticleId IdType="pubmed">30014440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S, Sakai Y, Okabe A, Kawashima Y, Kuwahara K, Shiogama K, et al. Histology of cardiac sarcoidosis with novel considerations arranged upon a pathologic basis. J Clin Med. (2022) 11(1):251. 10.3390/jcm11010251</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11010251</ArticleId><ArticleId IdType="pmc">PMC8746035</ArticleId><ArticleId IdType="pubmed">35011991</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>